Canada· CA-DIN-02452863

NASAL DECONGESTANT SPRAY WITH MOISTURIZERS

A xylometazoline product containing xylometazoline hydrochloride, registered in Canada by CRLS. The same ATC class is registered in 14 of our 19 countries.

ATC R01AA07

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about xylometazoline hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Xylometazoline is registered in 14 of 19 countries.

Countries holding a registration under ATC R01AA07 (xylometazoline), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
8 of them publish a price we can compare per daily dose

Search xylometazoline products by name

Xylometazoline · ATC R01AA07

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: XYLOMETAZOLINE HYDROCHLORIDE
Manufacturer: CRLS
Country: Canada (CA)
ATC code: R01AA07
ATC class: Xylometazoline
Defined daily dose: 0.8 mg, N
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for xylometazoline.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check xylometazoline against other medicines How interaction checks work

Xylometazoline · interactions on record

63 records

6 severe
54 moderate

Most severe, free to view

MethylergometrineG02AB01severe
DihydroergotamineN02CA01severe
ErgotamineN02CA02severe
MethysergideN02CA04severe

3 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Xylometazoline in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All xylometazoline products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Easynasan, Easynasan Junior
Belgium · Nasa Rhinathiol, Nasasinuspray Abschwellend
Bulgaria · Ксилогел, Ксилометазолин Wzf
Cyprus · Hexarhinal, Nasoxyl
Czechia · Mar Rhino, Nasenspray
Germany · Hysan Schnupfenspray, Hysan Schnupfenspray Kinder
Denmark · Klarigen, Otrivin Junior Ukonserveret
Estonia · Galazolin, Mindea
Spain · Amidrin, Idasal
Finland · Nasment, Naso
United Kingdom (Northern Ireland) · Clear Nose Spray, Nasoclear Decongestant
Greece · Hexarhinal, Noselif
Croatia · Meralys, Meralys Duo
Hungary · Lolimarine Ha, Lolimarine Ha Kid
Ireland · Otrivine Adult, Otrivine Adult Menthol
Iceland · Nasogen Menthol, Nasogen Normal
Italy · Actifed Decongestionante, Deltarindek Decongestionante
Lithuania · Eucamidin, Galazolin
Luxembourg · Nasa Rhinathiol, Nasasinuspray Décongestionnant
Latvia · Galazolin, Ksilonex
Malta · Hysan Adults, Hysan Paediatric
Netherlands · Albert Heijn Menthol, Coldrex Xylosel
Norway · Naso, Otrivin
Poland · Orinox, Orinox Ha
Portugal · Actifed Descongestionante Sem Conservantes, Nasex
Romania · Bixtonim Xylo, Bixtonim Xylo Aroma
Sweden · Nasoferm, Nasoferm Mentol
Slovenia · Maresyl, Maresyl 0,5 Mg/Ml
Slovakia · Mar Rhino, Olynth

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/1580cd0e-32f5-4116-8fe3-27aa13ba6c80
GET /v1/drugs/1580cd0e-32f5-4116-8fe3-27aa13ba6c80?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02452863",
  "form": "SPRAY",
  "class": "Human",
  "routes": [
    "NASAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "R01AA07",
  "schedule": [
    "OTC"
  ],
  "drug_code": "93927",
  "strengths": [
    "0.1 %"
  ],
  "ahfs_class": null,
  "substances": [
    "XYLOMETAZOLINE HYDROCHLORIDE"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about xylometazoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console